GSK, Copenhagen, Denmark.
University of Franche-Comte, Besançon, France.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2334475. doi: 10.1080/21645515.2024.2334475. Epub 2024 Apr 17.
Adult vaccination coverage remains low, despite vaccine recommendations, improved access, and reimbursement. Low vaccination coverage and an aging population at higher risk from vaccine-preventable diseases lead to preventable disability and deaths, straining healthcare systems. An Advisory Board meeting was, therefore, held to identify non-structural barriers to adult vaccination and discuss potential solutions to increase uptake. Many non-structural factors can influence vaccine uptake, such as heterogeneity in the population, (fear of) vaccine shortages, incentives, or mandates for vaccination, understanding of disease burden and personal risks, time and opportunity for healthcare providers (HCPs) to discuss and deliver vaccines during general practice or hospital visits, trust in the health system, and education. To address these barriers, push-pull mechanisms are required: to pull patients in for vaccination and to push HCP performance on vaccination delivery. For patients, the focus should be on lifelong prevention and quality of life benefits: personal conversations are needed to increase confidence and knowledge about vaccination, and credible communication is required to build trust in health services and normalize vaccination. For providers, quality measurements are required to prioritize vaccination and ensure opportunities to check vaccination status, discuss and deliver vaccines are not missed. Financial and quality-based incentives may help increase uptake.
尽管有疫苗接种建议、改善了的疫苗可及性和报销政策,成人疫苗接种率仍然很低。低疫苗接种率和高风险的老龄化人群易患可通过疫苗预防的疾病,导致可预防的残疾和死亡,给医疗保健系统带来压力。因此,举行了一次顾问委员会会议,以确定成人疫苗接种的非结构性障碍,并讨论增加接种率的潜在解决方案。许多非结构性因素会影响疫苗接种率,例如人群中的异质性、(对)疫苗短缺的担忧、疫苗接种的激励措施或强制要求、对疾病负担和个人风险的理解、医疗保健提供者(HCP)在一般实践或医院就诊期间讨论和提供疫苗的时间和机会、对卫生系统的信任以及教育。为了解决这些障碍,需要采用推拉机制:将患者拉进来接种疫苗,并推动 HCP 在疫苗接种方面的表现。对于患者,重点应放在终身预防和提高生活质量上:需要进行个人对话,以提高对疫苗接种的信心和认识,需要进行可信的沟通,以建立对卫生服务的信任,并使疫苗接种正常化。对于提供者,需要进行质量测量,以优先考虑疫苗接种,并确保有机会检查疫苗接种状况、讨论和提供疫苗接种。财务和基于质量的激励措施可能有助于提高接种率。